PRUCALOPRIDE MEDTAS prucalopride (as succinate) 1 mg film-coated tablet blister pack

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Laadi alla Avaliku hindamisaruande (PAR)
21-10-2022

Toimeaine:

prucalopride succinate, Quantity: 1.32 mg (Equivalent: prucalopride, Qty 1 mg)

Saadav alates:

MedTAS Pty Ltd

Ravimvorm:

Tablet, film coated

Koostis:

Excipient Ingredients: lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; triacetin; macrogol 3000

Manustamisviis:

Oral

Ühikuid pakis:

28 film-coated tablets

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

Prucalopride is indicated for the treatment of chronic functional constipation in adults in whom laxatives fail to provide adequate relief. ? Before Prucalopride is considered patients must have tried at least two different types of laxatives from different classes (at the highest tolerated recommended doses) for at least six months, but have not had adequate relief from constipation. ? If treatment with Prucalopride is not effective within four weeks, the benefit of continuing treatment should be reconsidered.

Toote kokkuvõte:

Visual Identification: White to off-white, round biconvex, film coated tablets debossed with P1 on one side and no debossing on the other side.; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Volitamisolek:

Registered

Loa andmise kuupäev:

2022-09-12